Page last updated: 2024-11-08

gingerdione

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

gingerdione: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID162952
CHEMBL ID2071439
CHEBI ID10135
SCHEMBL ID13469402
MeSH IDM0145027

Synonyms (19)

Synonym
gingerdione
61871-71-4
[6]-gingerdione
1-(4-hydroxy-3-methoxyphenyl)-3,5-decanedione
1-(4-hydroxy-3-methoxyphenyl)decane-3,5-dione
unii-l2l6jcl6yy
l2l6jcl6yy ,
3,5-decanedione, 1-(4-hydroxy-3-methoxyphenyl)-
chebi:10135 ,
CHEMBL2071439
6-gingerdione
6-gingerdione : n=6 (constituent of ginger) [dsc]
(6)-gingerdione
SCHEMBL13469402
KMNVXQHNIWUUSE-UHFFFAOYSA-N
DTXSID50210854
3,5-decadione, 1-(4-hydroxy-3-methoxyphenyl)
4,7-dichloro-benzo(b)thiophen-3(2h)-one
Q27108598
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
beta-diketoneA diketone in which the two keto groups are separated by a single carbon atom.
monomethoxybenzeneCompounds containing a benzene skeleton substituted with one methoxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID676749Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as reduction in isoniazid bromide MIC presence of test compound at 64 mg/L2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID676742Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as reduction in ciprofloxacin bromide MIC presence of test compound at 64 mg/L2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID676746Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as reduction in ethambutol bromide MIC presence of test compound at 64 mg/L2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID676752Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as reduction in rifampicin bromide MIC presence of test compound at 64 mg/L2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID676756Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as increase in normalized ethidium bromide fluorescence efflux at 0.5 MIC level by fluorimetric assay (Rvb = 0.581 +/- 0.051 ratio)2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID676740Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as reduction in ethidium bromide MIC presence of test compound at 64 mg/L2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID676744Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as fractional inhibitory concentration index in presence of ethidium bromide2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID676755Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as increase in relative ethidium bromide fluorescence accumulation at 0.5 MIC level by fluorimetric assay (Rvb = 6057.1 +/- 508.6 RFU)2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID676736Antimicrobial activity against Mycobacterium smegmatis str. MC2 155 ATCC 700084 incubated for 72 hrs in 7H9 T medium supplemented with 10% Middlebrook ADC enrichment by MTT assay2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID676737Antimicrobial activity against Mycobacterium smegmatis str. MC2 155 ATCC 700084 incubated for 72 hrs in Mueller-Hinton broth medium by MTT assay2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
AID676754Inhibition of Multidrug resistance efflux pump in Mycobacterium smegmatis str. MC2 155 ATCC 700084 assessed as fractional inhibitory concentration index in presence of rifampicin2012Journal of natural products, Jul-27, Volume: 75, Issue:7
Putative mycobacterial efflux inhibitors from the seeds of Aframomum melegueta.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (14.29)18.7374
1990's0 (0.00)18.2507
2000's4 (28.57)29.6817
2010's5 (35.71)24.3611
2020's3 (21.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.21 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.11 (4.65)
Search Engine Demand Index25.99 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]